Aimmune Therapeutics, Inc. (20)

Browse by Contract Category

Contracts

Agreement and Plan of Merger, dated as of August 29, 2020, by and among Aimmune Therapeutics, Inc., Socits des Produits Nestl S.A., and SPN MergerSub, Inc (Filed With SEC on August 31, 2020)
Form of Global Restricted Stock Unit Grant Notice and Award Agreement (Filed With SEC on July 31, 2020)
Non-Employee Director Compensation Program (Filed With SEC on May 11, 2020)
Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 27, 2020)
Third Amendment to Office Lease, dated December 20, 2019, by and between the Company and HCP Life Science REIT, Inc (Filed With SEC on February 27, 2020)
Amended and Restated Strategic Collaboration Agreement, dated February 4, 2020, by and between the Company and Socit des Produits Nestl S.A (Filed With SEC on February 5, 2020)
License Agreement, dated February 4, 2020, by and among, Aimmune Therapeutics, Inc. and Xencor, Inc (Filed With SEC on February 5, 2020)
Form of Global Stock Option Grant Notice and Award Agreement (Filed With SEC on July 31, 2020)
Commercial Packaging Agreement, dated November 11, 2019, by and between AndersonBrecon Inc. and Aimmune Therapeutics, Inc (Filed With SEC on February 27, 2020)
Securities Purchase Agreement, dated February 4, 2020, by and between the Company and Nestle Health Science US Holdings, Inc (Filed With SEC on February 5, 2020)
Amended and Restated Registration Rights Agreement, dated February 4, 2020, by and between the Company and Nestle Health Science US Holdings, Inc (Filed With SEC on February 5, 2020)
Amended and Restated Standstill Agreement, dated February 4, 2020, by and between the Company and Nestle Health Science US Holdings, Inc (Filed With SEC on February 5, 2020)
Letter Agreement, dated December 19, 2019, between the Company and Stephen G. Dilly, M.B.B.S., Ph.D (Filed With SEC on December 20, 2019)
Office Lease dated February 23, 2015, by and between, the Company, Diamond Marina LLC and Diamond Marina II LLC in June 2019 (Filed With SEC on August 8, 2019)
Commercial Supply Agreement, dated May 10, 2019, by and between CoreRx, Inc. and Aimmune Therapeutics, Inc (Filed With SEC on August 8, 2019)
Letter Agreement, dated June 13, 2019, by and between the Company and Stephen G. Dilly, M.B.B.S., Ph.D (Filed With SEC on August 8, 2019)
Amended and Restated Standstill Agreement, dated November 11, 2018, by and between the Company and Nestle Health Science US Holdings, Inc (Filed With SEC on February 28, 2019)
Amended and Restated Strategic Collaboration Agreement, dated November 11,2018, by and between the Company and Nestec Ltd (Filed With SEC on February 28, 2019)
Securities Purchase Agreement, dated November 11, 2018, by and between the Company and Nestle Health Science US Holdings, Inc (Filed With SEC on February 28, 2019)
Amended and Restated Registration Rights Agreement, dated November 11, 2018, by and between the Company and Nestle Health Science US Holdings, Inc (Filed With SEC on February 28, 2019)